Control of E2F activity by p21Waf1/Cip1

L Delavaine1, N B La Thangue

  • 1Division of Biochemistry and Molecular Biology, Davidson Building, University of Glasgow, Glasgow, G12 8QQ, UK.

Oncogene
|September 28, 1999
PubMed

Insights

Cyclin-dependent kinase inhibitors like p21 regulate cell proliferation. New findings suggest p21 controls E2F transcription factors independently of pRb, offering novel insights into cell cycle control.

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Cancer Research

Background:

  • Cyclin-dependent kinase inhibitors (cdkis) control proliferation by inhibiting cyclin-dependent kinases (cdks).
  • The p21 gene, a target of p53, is crucial for the p53 response.
  • p21 is known to influence cell cycle progression via cdk control of the retinoblastoma protein (pRb).

Purpose of the Study:

  • To investigate a novel p21-dependent mechanism regulating E2F transcription factors.
  • To explore pathways of E2F regulation independent of cdk/pRb interactions.

Main Methods:

  • Investigated the interaction between p21 and E2F subunits.
  • Assessed p21's effect on transcription in vitro.
  • Analyzed cell cycle regulation pathways.

Main Results:

  • Identified a p21-dependent mechanism regulating E2F activity independent of pRb.
  • Demonstrated that p21 can associate with E2F subunits.
  • Showed that p21 can directly regulate transcription in vitro.

Conclusions:

  • p21 may control E2F activity through a mechanism independent of the retinoblastoma protein (pRb).
  • p21's interaction with E2F subunits suggests a direct role in transcriptional regulation.
  • These findings reveal a new layer of cell cycle control mediated by p21.

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...